We are live on ! Find out more
BMY icon

Bristol-Myers Squibb
BMY

1,179 hedge funds and large institutions have $49.8B invested in Bristol-Myers Squibb in 2013 Q2 according to their latest regulatory filings, with 1,179 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.53% more ownership

Funds ownership: 0% → 68.53% (+69%)

1% more call options, than puts

Call options by funds: $519M | Put options by funds: $516M

Holders
1,179
Holders Change
+1,179
Holders Change %
–
% of All Funds
38.47%
Holding in Top 10
49
Holding in Top 10 Change
+49
Holding in Top 10 Change %
% of All Funds
1.6%
New
1,179
Increased
–
Reduced
–
Closed
–
Calls
$519M
Puts
$516M
Net Calls
+$2.99M
Net Calls Change
+$2.99M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
OMC
1026
Overbrook Management Corp
New York
$295K +$286K +6,590 New
GWM
1027
Greenwich Wealth Management
Connecticut
$295K +$286K +6,595 New
CCM
1028
Coldstream Capital Management
Washington
$295K +$287K +6,601 New
RHJA
1029
Rice Hall James & Associates
California
$294K +$286K +6,588 New
EBSAM
1030
Eubel Brady & Suttman Asset Management
Ohio
$292K +$284K +6,542 New
AFG
1031
Albion Financial Group
Utah
$291K +$283K +6,509 New
MPAM
1032
Murphy Pohlad Asset Management
Minnesota
$291K +$283K +6,513 New
BOS
1033
Bingham Osborn & Scarborough
California
$290K +$281K +6,480 New
GIM
1034
Greylin Investment Management
Virginia
$290K +$282K +6,500 New
LOM
1035
Loeb Offshore Management
New York
$290K +$282K +6,500 New
WCA
1036
Westover Capital Advisors
Delaware
$290K +$282K +6,500 New
YMRC
1037
Yorktown Management & Research Company
Virginia
$290K +$282K +6,500 New
WSA
1038
Willow Street Advisors
Florida
$289K +$165K +3,800 New
BMC
1039
Benin Management Corp
Connecticut
$288K +$280K +6,443 New
WCM
1040
Weik Capital Management
Pennsylvania
$285K +$277K +6,375 New
SC
1041
Savant Capital
Illinois
$285K +$277K +6,385 New
MIM
1042
Montgomery Investment Management
Maryland
$280K +$272K +6,260 New
BRM
1043
Boston Research & Management
Massachusetts
$279K +$272K +6,260 New
CTA
1044
Colonial Trust Advisors
South Carolina
$277K +$269K +6,202 New
ECM
1045
Evergreen Capital Management
Washington
$275K +$267K +6,145 New
TAM
1046
Trillium Asset Management
Massachusetts
$272K +$264K +6,090 New
TAM
1047
Taurus Asset Management
New York
$270K +$262K +6,043 New
WA
1048
Waverly Advisors
Alabama
$268K +$261K +6,002 New
SFI
1049
SPC Financial Inc
Maryland
$266K +$259K +5,960 New
BSB
1050
Bangor Savings Bank
Maine
$265K +$258K +5,935 New
40 41
42
43 44

BMY Hedge Fund Activity: Q2 2013 in Review

1,179 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q2 2013, worth a combined $49.8B.

Buyers outnumbered sellers: 1,179 funds opened new BMY positions and 0 closed out — a net gain of 1,179 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,179 institutional investors held Bristol-Myers Squibb (BMY) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $49.8B of Bristol-Myers Squibb stock for Q2 2013.
  • 1,179 funds opened new Bristol-Myers Squibb positions in Q2 2013 and 0 closed out, a net change of +1,179 holders.

Based on aggregated 13F filings for Q2 2013.